Legal attitude: Art. 17 para. 1 MAR - confidential information. Br> In reference to the current report of ESPI No. 12/2017 dated 18 May 2017, the Management Board of BLIRT S.A. (Issuer) informs that on August 1, 2017, the Extraordinary General Meeting of Shareholders of Transmedium Sp. z o.o. (a subsidiary of the Issuer, in which the Issuer holds 76.91% of shares) has adopted a resolution to terminate Transemdium Sp. z oo, opening its liquidation and appointing the liquidator. br> How the Issuer informed previously (ESPI Current Report No. 6/2017 of 08/02/2017) during the implementation of the project of an innovative 2nd generation fluid for transplantation (Project) Transmedium has encountered for production problems. In the absence of the possibility of obtaining financing enabling further implementation of the Project, the Company decided to abandon its continuation and start liquidating the Company. Br>
Source: company website, investor relations, current and periodic reports.